Hospira Recalls Lidocaine Hydrochloride Injection Due to Particulate Matter
Hospira Inc. is recalling 120,900 vials of 1% Lidocaine Hydrochloride Injection because iron oxide particulates were found in the solution.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The agency classification is FDA Class I, which mandates a minimum severity score of 4 according to the rubric, as it represents a reasonable probability of serious adverse health consequences or death.
Plain-English summary
Hospira Inc. is recalling 120,900 vials of 1% Lidocaine Hydrochloride Injection, USP, Preservative-Free, 10 mg/mL, 30 mL Single-dose vials. The affected product is packaged in 25-count cartons and is available by prescription only. The specific lot number is 31-427-DK with an expiration date of 01JUL2015.
The recall was initiated after a confirmed customer complaint identified orange and black particulates, which were identified as iron oxide, embedded within the glass vial and floating in the solution. This particulate matter presents a potential safety risk for patients receiving the injection.
The affected product was distributed nationwide. Consumers and healthcare providers should stop using the recalled vials and contact their pharmacist or physician for guidance on alternative treatments or returns.
The recalled product
- Product
- LIDOCAINE HYDROCHLORIDE (LIDOCAINE HYDROCHLORIDE)
- Brand
- LIDOCAINE HYDROCHLORIDE
- Manufacturer
- Hospira Inc.
- Category
- Drug — Injection
- Affected units
- 120,900
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot number: 31-427-DK
- Exp 01JUL2015.
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · LIDOCAINE HYDROCHLORIDE
- SevereLidocaine Hydrochloride Injection Recalled for Sterility Assurance
FDA (Drugs) · 2026-07-08
- HighSpectra lidocaine ampules recalled over lack of sterility assurance
FDA (Drugs) · 2026-06-10
- HighHuons lidocaine injection recalled nationwide over lack of sterility assurance
FDA (Drugs) · 2026-04-22
- HighHuons lidocaine 2% injection recalled over lack of sterility assurance
FDA (Drugs) · 2026-04-22
- SeverePfizer Lidocaine Injection Recall: Glass Particulates in Injectable Medication
FDA (Drugs) · 2023-11-15
Same manufacturer · Hospira Inc.
See all →- CriticalHospira Recalls Dextrose Injection Syringes Due to Human Hair Particulate
FDA (Drugs) · 2017-05-31
- ModerateHospira Recalls Minibore Extension Sets Due to Solvent Occlusion
FDA (Devices) · 2017-01-18
- LowHospira Recalls Lidocaine and Dextrose Injection for Stability Failures
FDA (Drugs) · 2016-12-14
- SevereHospira Recalls Fentanyl Citrate Injection Ampules Due to Broken Tips
FDA (Drugs) · 2016-11-30
- HighHospira Symbiq Infusion Pump Recall for White Screen Safety Shutdown
FDA (Devices) · 2016-11-16
Same hazard · particulate matter
See all →- SevereACTHAR Gel Recalled for Presence of Glass and Stopper Particulate Matter
FDA (Drugs) · 2026-09-02
- SevereB. Braun Recalls Lactated Ringer's Injection Due to Particulate Matter
FDA (Drugs) · 2026-09-02
- CriticalAmerican Regent Recalls Papaverine Hydrochloride Injection Due to Particulate Matter
FDA (Drugs) · 2026-08-26
- SevereAmerican Regent Recalls Nitroglycerin Injection Due to Particulate Matter
FDA (Drugs) · 2026-08-26
- SevereAmerican Regent Recalls Cyanocobalamin Injections Due to Particulate Matter
FDA (Drugs) · 2026-08-26